Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: hal jordan who wrote (5937)	3/17/1998 12:36:00 PM
From: Steve J.	Respond to of 23519

It would seem that MCA approval is already factored into the price. Everybody knew MCA approval was going to happen around this time. If it did not occur I believe it would have had an adverse affect on price. I'm guessing the Viagra issues are having a bigger affect on Vivus than anything else. There has been a tremendous amount of positive PR put out on Viagra with relatively nothing out there relating to MUSE. It would seem wise to wait until the streets expectations on these issues are more clear. There should be plenty of time later to purchase at a good price prior to any run up. Just thoughts to ponder.

To: hal jordan who wrote (5937)	3/17/1998 1:43:00 PM
From: RT	Respond to of 23519

<<we are still under $12. Apparently, this approval does not mean that much to the street>>. Hal, The response to this long awaited approval has been muted to say the least. Perhaps some news from Vivus pertaining to the amount of product being shipped to the UK this quarter, as well as some analysts upgrades might reverse this downward trend. Regardless, this news was good and it's one less obstacles in our way. Now all we have to concern ourselves with, is the FDA approval, Viagara, and the lawsuits RT.